Our previous results demonstrated that TAB2 promotes cancer stemness through NF‐κB pathway activation, as evidenced by enhanced sphere formation capacity and increased expression of stem cell markers SOX2 and BMI1. The gene discussed is TAB2; the disease is cancer.